Efficacy and safety of mavacamten therapy in hypertrophic cardiomyopathy: An up-to-date systematic review and meta-analysis

11 May 2024 (14:42 - 15:51)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease 2 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by